| http://dbpedia.org/ontology/abstract
|
United States v. Glaxo Group Ltd., 410 U.S … United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a 1973 decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, "[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies."harges are recognized antitrust remedies."
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Justice_White_Official.jpg?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://www.oyez.org/cases/1972/71-666 +
, https://law.justia.com/cases/federal/district-courts/FSupp/328/709/1428190/ +
, http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl%3Fcourt=US&vol=410&invol=52 +
, http://cdn.loc.gov/service/ll/usrep/usrep410/usrep410052/usrep410052.pdf +
, http://supreme.justia.com/us/410/52/case.html +
|
| http://dbpedia.org/ontology/wikiPageID
|
20316461
|
| http://dbpedia.org/ontology/wikiPageLength
|
8407
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1102284022
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Byron_White +
, http://dbpedia.org/resource/GlaxoSmithKline +
, http://dbpedia.org/resource/Supreme_Court_of_the_United_States +
, http://dbpedia.org/resource/Imperial_Chemical_Industries +
, http://dbpedia.org/resource/CCH_%28company%29 +
, http://dbpedia.org/resource/U.S._LEXIS +
, http://dbpedia.org/resource/Category:United_States_patent_case_law +
, http://dbpedia.org/resource/Sherman_Act +
, http://dbpedia.org/resource/Patent +
, http://dbpedia.org/resource/Cross-licensing +
, http://dbpedia.org/resource/F._Supp. +
, http://dbpedia.org/resource/United_States_Department_of_Justice +
, http://dbpedia.org/resource/Potter_Stewart +
, http://dbpedia.org/resource/United_States_Patents_Quarterly +
, http://dbpedia.org/resource/L._Ed._2d +
, http://dbpedia.org/resource/Bloomberg_BNA +
, http://dbpedia.org/resource/Category:GSK_plc_litigation +
, http://dbpedia.org/resource/Harry_Blackmun +
, http://dbpedia.org/resource/Patent_pool +
, http://dbpedia.org/resource/Griseofulvin +
, http://dbpedia.org/resource/Category:United_States_antitrust_case_law +
, http://dbpedia.org/resource/Category:1973_in_United_States_case_law +
, http://dbpedia.org/resource/File:Justice_White_Official.jpg +
, http://dbpedia.org/resource/Category:United_States_Supreme_Court_cases +
, http://dbpedia.org/resource/Category:Standing_%28law%29 +
, http://dbpedia.org/resource/D.D.C. +
, http://dbpedia.org/resource/United_States_Department_of_Justice_Antitrust_Division +
, http://dbpedia.org/resource/Category:Legal_doctrines_and_principles +
, http://dbpedia.org/resource/Test_case +
, http://dbpedia.org/resource/Category:United_States_Supreme_Court_cases_of_the_Burger_Court +
, http://dbpedia.org/resource/Antitrust +
, http://dbpedia.org/resource/William_Rehnquist +
|
| http://dbpedia.org/property/arguedate
|
--11-09
|
| http://dbpedia.org/property/argueyear
|
1972
|
| http://dbpedia.org/property/case
|
United States v. Glaxo Group Ltd.,
|
| http://dbpedia.org/property/decidedate
|
--01-22
|
| http://dbpedia.org/property/decideyear
|
1973
|
| http://dbpedia.org/property/dissent
|
Rehnquist
|
| http://dbpedia.org/property/findlaw
|
http://caselaw.lp.findlaw.com/cgi-bin/getcase.pl%3Fcourt=US&vol=410&invol=52 +
|
| http://dbpedia.org/property/fullname
|
United States v. Glaxo Group Ltd.
|
| http://dbpedia.org/property/holding
|
When a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent.
|
| http://dbpedia.org/property/joindissent
|
Stewart and Blackmun
|
| http://dbpedia.org/property/joinmajority
|
Burger, Douglas, Brennan, Marshall, Powell
|
| http://dbpedia.org/property/justia
|
http://supreme.justia.com/us/410/52/case.html +
|
| http://dbpedia.org/property/lawsapplied
|
http://dbpedia.org/resource/Sherman_Act +
|
| http://dbpedia.org/property/litigants
|
United States v. Glaxo Group Ltd.
|
| http://dbpedia.org/property/loc
|
http://cdn.loc.gov/service/ll/usrep/usrep410/usrep410052/usrep410052.pdf +
|
| http://dbpedia.org/property/majority
|
White
|
| http://dbpedia.org/property/oyez
|
https://www.oyez.org/cases/1972/71-666 +
|
| http://dbpedia.org/property/parallelcitations
|
172800.0
|
| http://dbpedia.org/property/prior
|
328
|
| http://dbpedia.org/property/uspage
|
52
|
| http://dbpedia.org/property/usvol
|
410
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_SCOTUS_case +
, http://dbpedia.org/resource/Template:Ussc +
, http://dbpedia.org/resource/Template:Caselaw_source +
, http://dbpedia.org/resource/Template:BBstyle +
, http://dbpedia.org/resource/Template:Reflist +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:United_States_Supreme_Court_cases +
, http://dbpedia.org/resource/Category:United_States_patent_case_law +
, http://dbpedia.org/resource/Category:United_States_antitrust_case_law +
, http://dbpedia.org/resource/Category:1973_in_United_States_case_law +
, http://dbpedia.org/resource/Category:GSK_plc_litigation +
, http://dbpedia.org/resource/Category:Legal_doctrines_and_principles +
, http://dbpedia.org/resource/Category:United_States_Supreme_Court_cases_of_the_Burger_Court +
, http://dbpedia.org/resource/Category:Standing_%28law%29 +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/United_States_v._Glaxo_Group_Ltd.?oldid=1102284022&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Justice_White_Official.jpg +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/United_States_v._Glaxo_Group_Ltd. +
|
| http://xmlns.com/foaf/0.1/name
|
United States v. Glaxo Group Ltd.
|
| owl:sameAs |
https://global.dbpedia.org/id/4wsLf +
, http://www.wikidata.org/entity/Q7893300 +
, http://dbpedia.org/resource/United_States_v._Glaxo_Group_Ltd. +
, http://yago-knowledge.org/resource/United_States_v._Glaxo_Group_Ltd. +
, http://rdf.freebase.com/ns/m.04z_mf8 +
|
| rdf:type |
http://dbpedia.org/class/yago/Happening107283608 +
, http://dbpedia.org/class/yago/Abstraction100002137 +
, http://dbpedia.org/class/yago/PsychologicalFeature100023100 +
, http://dbpedia.org/ontology/SupremeCourtOfTheUnitedStatesCase +
, http://www.wikidata.org/entity/Q2334719 +
, http://dbpedia.org/class/yago/WikicatUnitedStatesSupremeCourtCases +
, http://dbpedia.org/ontology/UnitOfWork +
, http://dbpedia.org/ontology/LegalCase +
, http://dbpedia.org/class/yago/Case107308889 +
, http://dbpedia.org/class/yago/Event100029378 +
, http://dbpedia.org/ontology/Case +
, http://dbpedia.org/class/yago/YagoPermanentlyLocatedEntity +
|
| rdfs:comment |
United States v. Glaxo Group Ltd., 410 U.S … United States v. Glaxo Group Ltd., 410 U.S. 52 (1973), is a 1973 decision of the United States Supreme Court in which the Court held that (1) when a patent is directly involved in an antitrust violation, the Government may challenge the validity of the patent; and (2) ordinarily, in patent-antitrust cases, "[m]andatory selling on specified terms and compulsory patent licensing at reasonable charges are recognized antitrust remedies."harges are recognized antitrust remedies."
|
| rdfs:label |
United States v. Glaxo Group Ltd.
|
